SITC Resource Library

Presentation slides and video from the 2024 Advances in Cancer Immunotherapy^™ (ACI) Series: A Focus on Intratumoral Therapies, Vaccines and Cytokines were presented virtually on October 9, 2024.

Program Organizers

• Lei Zheng, MD, PhD – Johns Hopkins University
• Mark P. Rubinstein, PhD – The Ohio State University
• Wil Ngwa, PhD, MSc – Johns Hopkins University

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Program Learning Objectives

• Describe the mechanisms of intratumoral therapies, vaccines and cytokines.
• Summarize recent updates in the use of intratumoral therapies, vaccines and cytokines clinically.
• Outline common toxicities with intratumoral therapies, vaccines and cytokines and their management.

You can view the program agenda here.

Please note on-demand recordings are not available for continuing education credits.